Teza Capital Management LLC Catalent, Inc. Transaction History

Teza Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$53.58 - $57.02 $389,901 - $414,934	7,277 New	7,277 $409,000
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $166,821 - $241,418	-5,184 Reduced 39.51%	7,938 $356,000
Q3 2023 Feb 22, 2024	BUY	$44.2 - $50.2 $51,935 - $58,985	1,175 Added 17.86%	7,755 $353,000
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $579,992 - $658,724	13,122 New	13,122 $597,000
Q1 2023 Feb 22, 2024	SELL	$45.44 - $74.26 $61,707 - $100,845	-1,358 Reduced 17.11%	6,580 $432,000
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $163,538 - $267,261	3,599 Added 58.31%	9,771 $642,000
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $255,459 - $499,932	6,172 New	6,172 $277,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.